ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 170 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $775 | +46.5% | 26,549 | +58.3% | 0.02% | -29.2% |
| Q4 2023 | $529 | -5.0% | 16,774 | -23.1% | 0.02% | +4.3% |
| Q3 2023 | $557 | -12.4% | 21,804 | -1.7% | 0.02% | -8.0% |
| Q2 2023 | $636 | -10.7% | 22,181 | -25.3% | 0.02% | -16.7% |
| Q1 2023 | $712 | +164.7% | 29,698 | +87.3% | 0.03% | +150.0% |
| Q4 2022 | $269 | -99.6% | 15,855 | +950.0% | 0.01% | +500.0% |
| Q3 2020 | $65,000 | -8.5% | 1,510 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $71,000 | – | 1,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 484,907 | $11,807,485 | 0.97% |
| Nikko Asset Management Americas, Inc. | 1,563,065 | $37,966,849 | 0.44% |
| Diametric Capital, LP | 32,765 | $797,827 | 0.43% |
| ARK Investment Management | 1,964,964 | $47,846,871 | 0.42% |
| SummerHaven Investment Management, LLC | 23,400 | $569,790 | 0.38% |
| Quantedge Capital Pte Ltd | 40,800 | $993,480 | 0.36% |
| Granahan Investment Management | 344,549 | $8,389,768 | 0.34% |
| FEDERATED HERMES, INC. | 4,694,060 | $114,300,361 | 0.27% |
| Belmont Capital, LLC | 40,000 | $974,000 | 0.18% |
| Woodline Partners LP | 754,023 | $18,360,460 | 0.18% |